Guidelines for Initial Therapy for Common Pediatrics Infections (PDF)
Acute Leukemia Antimicrobial and Antifungal Prophylaxis Guidelines (PDF)
Antibiotic Prophylaxis in ECMO Patients: Cannulation in Sterile Setting and Cannulation in Non-Sterile Setting
Appendicitis Antibiotic Selection Guideline
Drug-Susceptible Tuberculosis Therapy Guideline (PDF) and ID Fellow’s TB Guide
ENT Peri-Operative Antibiotic Prophylaxis Guidelines
Fever in Infants (8 to 21 days old) Pathway
Fever and Neutropenia Guidelines in Pediatric Oncology
Liver Transplant Post-Op Antimicrobial Selection and Duration
Neonatal and Young Infant (7-60 day) Urinary Tract Infection Pathway
NICU Late Onset Sepsis Algorithm
Pediatric Sepsis and Septic Shock Pathway
Prolonged Fever and Neutropenia Pathway
RSV Infant Prophylaxis: Nirsevimab (Beyfortus®) Guideline
Skin and Soft Tissue Infections
Surgical Prophylaxis Guidelines:
Antimicrobial Monitoring Guidelines (PDF)
Amoxicillin-clavulanate (Augmentin®) Dosing Guide (PDF)
Azole Antifungal Therapeutic Drug Monitoring Guidance
LPCH Blue Card – Antibiogram and Antimicrobial Dosing Quick Reference Card (PDF)
Pediatric Renal Antibiotic Dosing Recommendations
Prolonged Infusion of Beta-Lactam Guidelines
Vancomycin per Pharmacy
Antibiotic Desensitization Protocol
Antibiotic Graded Challenge Protocol
Allergy Clinical Decision Support Tool
– Antibiotic Allergy Clinical Decision Support Tool
– Antibiotic Allergy Tool – Rationale Document
– Antibiotic Allergy Tool Instructions Powerpoint (PPTX)
– Video Tutorial
List of restricted antimicrobials at LPCH
ASP Restricted Antimicrobial Approval Process
Nirsevimab Monoclonal Antibody Memo
Vaccination
COVID-19 Vaccine 2024-2025 Memo
Treatment
COVID-19 Inpatient Treatment Algorithm
LPCH Therapies for High-Risk Nonhospitalized Patients with Mild to Moderate COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) Pathway
Connect with us:
Download our App: